Clinical outcome of autologous mononuclear cells transplantation for spinal cord injury: a systematic review and meta-analysis.

Cell-based therapies can be used to treat neurological diseases and spinal cord injuries. The aim of this study was to assess the clinical outcome of bone marrow derived mononuclear cells (BM-MNCs) transplantation in patients with spinal cord injuries.